DCF Valuation Model for Invex Therapeutics, page-153

	IXC	BIT
1	22 mill cash on hand	6 mill cash on hand
2	Phase 3 IIH	Phase 2 HIV Phase 2 Covid 19
3	Fully funded to the end of phase 3 trials	Multiple raises still to be conducted in the future
4	33 mill MC	24 mill MC
5

There are multiple examples of other biotech companies trading similar to IXC yet a miles behind. Yes TAM is larger but, they haven't even had successful phase 2 trials + they have competitors within there space where as IXC is the only one. It just astounding the discount the market is putting on IXC, cant wait to see this updated top 20 to see who is the culprit here, and I am still surprised by the selling coming through.

Does anyone know what the next sites IXC is looking to activate?

Ive met 2 people in the past month who have had IIH, so it seems this disease is becoming more known to GPs. Might have been coincidental, but before that I didn't know anyone who had ever had it before (probably due to misdiagnosis).